2-(2,5-Dioxopyrrolidin-1-yl)-1,1,3,3-tetramethylisouronium tetrafluoroborate → HCID 88946728, compound
Reaction equation
[C:1]([O:5][C:6](=[O:78])[C@@H:7]([NH:13][C:14](=[O:77])[CH2:15][CH2:16][C@@H:17]([C:70]([O:72][C:73]([CH3:76])([CH3:75])[CH3:74])=[O:71])[NH:18][C:19](=[O:69])[CH2:20][CH2:21][C@@H:22]([C:62]([O:64][C:65]([CH3:68])([CH3:67])[CH3:66])=[O:63])[NH:23][C:24](=[O:61])[CH2:25][CH2:26][C@@H:27]([C:54]([O:56][C:57]([CH3:60])([CH3:59])[CH3:58])=[O:55])[NH:28][C:29](=[O:53])[CH2:30][CH2:31][CH2:32][CH2:33][CH2:34][CH2:35][CH2:36][CH2:37][CH2:38][CH2:39][CH2:40][CH2:41][CH2:42][CH2:43][CH2:44][CH2:45][C:46]([O:48][C:49]([CH3:52])([CH3:51])[CH3:50])=[O:47])[CH2:8][CH2:9][C:10]([OH:12])=[O:11])([CH3:4])([CH3:3])[CH3:2].[B-](F)(F)(F)F.CN(C(O[N:92]1[C:97](=[O:98])[CH2:96][CH2:95][C:93]1=[O:94])=[N+](C)C)C>C(#N)C>[O:94]=[C:93]1[CH2:95][CH2:96][C:97](=[O:98])[N:92]1[O:11][C:10](=[O:12])[CH2:9][CH2:8][C@H:7]([NH:13][C:14](=[O:77])[CH2:15][CH2:16][C@@H:17]([C:70]([O:72][C:73]([CH3:76])([CH3:75])[CH3:74])=[O:71])[NH:18][C:19](=[O:69])[CH2:20][CH2:21][C@@H:22]([C:62]([O:64][C:65]([CH3:68])([CH3:67])[CH3:66])=[O:63])[NH:23][C:24](=[O:61])[CH2:25][CH2:26][C@@H:27]([C:54]([O:56][C:57]([CH3:58])([CH3:59])[CH3:60])=[O:55])[NH:28][C:29](=[O:53])[CH2:30][CH2:31][CH2:32][CH2:33][CH2:34][CH2:35][CH2:36][CH2:37][CH2:38][CH2:39][CH2:40][CH2:41][CH2:42][CH2:43][CH2:44][CH2:45][C:46]([O:48][C:49]([CH3:50])([CH3:51])[CH3:52])=[O:47])[C:6]([O:5][C:1]([CH3:2])([CH3:3])[CH3:4])=[O:78]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
(S)-2-((S)-4-tert-Butoxycarbonyl-4-{(S)-4-tert-butoxycarbonyl-4-[(S)-4-tert-butoxycarbonyl-4-(17-tert-butoxycarbonylheptadecanoylamino)butyrylamino]butyrylamino}butyrylamino)pentanedioic acid 1-tert-butyl ester (0.1 g, 0.09 mmol) was activated with TSTU (29.8 mg, 0.099 mmol) in acetonitrile solution at RT for 1 h using the same method for activation and work up as described above. This afforded 100 mg crude activated product which could be used as such for insulin acylation without further purification. LC-MS (electrospray): m/z=1208 (M+1).
Workup
- customwithout further purification
Sources & evidence
- ORD record
- ord-7dab692ae4514e8aa89425f9a9890058
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09045560B2
Reaction notes
Loading…